Mandatum Life Insurance Company’s Biogen BIIB Stock Holding History

Mandatum Life Insurance Company’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,204	Closed	-$3.03M	–	102
2019 Q4	$3.03M	Hold	10,204	–	–	0.63%	43
2019 Q3	$2.38M	Hold	10,204	–	–	0.48%	53
2019 Q2	$2.39M	Hold	10,204	–	–	0.5%	51
2019 Q1	$2.41M	Hold	10,204	–	–	0.52%	52
2018 Q4	$3.07M	Hold	10,204	–	–	0.73%	35
2018 Q3	$3.6M	Hold	10,204	–	–	0.68%	36
2018 Q2	$2.96M	Hold	10,204	–	–	0.57%	43
2018 Q1	$2.79M	Hold	10,204	–	–	0.52%	45
2017 Q4	$3.25M	Hold	10,204	–	–	0.51%	39
2017 Q3	$3.19M	Hold	10,204	–	–	0.43%	40
2017 Q2	$2.77M	Hold	10,204	–	–	0.38%	49
2017 Q1	$2.79M	Hold	10,204	–	–	0.36%	55
2016 Q4	$2.89M	Hold	10,204	–	–	0.39%	50
2016 Q3	$3.19M	Hold	10,204	–	–	0.42%	32
2016 Q2	$2.47M	Hold	10,204	–	–	0.34%	51
2016 Q1	$2.66M	Hold	10,204	–	–	0.36%	44
2015 Q4	$3.13M	Buy	+10,204	New	+$2.93M	0.43%	14

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mandatum Life Insurance Company's BIIB Position: Q1 2020 in Review

Mandatum Life Insurance Company sold out of Biogen (BIIB) in Q1 2020, closing a stake of 10,204 shares — an estimated $3.03M sold.

Mandatum Life Insurance Company first reported a position in BIIB in Q4 2015 and held it in 17 quarters. The position peaked at $3.6M in Q3 2018. 1,100 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

Mandatum Life Insurance Company reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
Mandatum Life Insurance Company sold 10,204 Biogen shares in Q1 2020, an estimated $3.03M.
Mandatum Life Insurance Company first reported a position in Biogen in Q4 2015 and held it in 17 quarters.
Mandatum Life Insurance Company's Biogen position peaked at $3.6M in Q3 2018.
1,100 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2020, filed 8 May 2020.